GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (HKSE:06996) » Definitions » PB Ratio

Antengene (HKSE:06996) PB Ratio : 0.52 (As of May. 31, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Antengene PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-31), Antengene's share price is HK$0.96. Antengene's Book Value per Share for the quarter that ended in Dec. 2023 was HK$1.86. Hence, Antengene's PB Ratio of today is 0.52.

The historical rank and industry rank for Antengene's PB Ratio or its related term are showing as below:

HKSE:06996' s PB Ratio Range Over the Past 10 Years
Min: 0.38   Med: 0.89   Max: 2.24
Current: 0.52

During the past 6 years, Antengene's highest PB Ratio was 2.24. The lowest was 0.38. And the median was 0.89.

HKSE:06996's PB Ratio is ranked better than
92.9% of 1309 companies
in the Biotechnology industry
Industry Median: 2.51 vs HKSE:06996: 0.52

During the past 12 months, Antengene's average Book Value Per Share Growth Rate was -34.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -29.70% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Antengene was -29.70% per year. The lowest was -29.70% per year. And the median was -29.70% per year.

Back to Basics: PB Ratio


Antengene PB Ratio Historical Data

The historical data trend for Antengene's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene PB Ratio Chart

Antengene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - 3.20 2.24 1.82 1.08

Antengene Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.24 1.81 1.82 0.65 1.08

Competitive Comparison of Antengene's PB Ratio

For the Biotechnology subindustry, Antengene's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Antengene's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Antengene's PB Ratio distribution charts can be found below:

* The bar in red indicates where Antengene's PB Ratio falls into.



Antengene PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Antengene's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.96/1.86
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Antengene  (HKSE:06996) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Antengene PB Ratio Related Terms

Thank you for viewing the detailed overview of Antengene's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Antengene (HKSE:06996) Business Description

Traded in Other Exchanges
N/A
Address
1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN
Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in China and other regions.
Executives
Jay Mei 2023 Grat 2201 Interest of corporation controlled by you
Mei Jay 2201 Interest of corporation controlled by you
Begonia Investment Ltd. 2101 Beneficial owner
Qiming Corporate Gp V, Ltd.
The Core Trust Company Limited 2301 Trustee
Tct (bvi) Limited 2501 Other
Fountainvest China Capital Partners Gp3 Ltd. 2201 Interest of corporation controlled by you
Fountainvest China Capital Partners Fund Iii, L.p. 2201 Interest of corporation controlled by you
Fmr Llc 2201 Interest of corporation controlled by you
Fidelity Investment Trust 2101 Beneficial owner
Jay Mei 2020 Grat 2201 Interest of corporation controlled by you
Meiland Pharma Tech Spc
Boyu Capital Group Holdings Ltd 2201 Interest of corporation controlled by you
Boyu Capital General Partner Iii, Ltd
Boyu Capital General Partner Iii, L.p.

Antengene (HKSE:06996) Headlines

No Headlines